
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [AXSM] Axsome Therapeutics Inc
Data updated 2023-Dec-27 (Wednesday)Compare current performance/technical metrics to history for Axsome Therapeutics Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2023-Dec-27 Wednesday
Day Change | +5.34% Top | Day Volatility | 5.89% Mid |
Streak | ↑ 4 days Top | % Streak | +18.51% Top |
RSI | 77 Top | CCI | 231.2 Top |
MACD | 0.97 Top | ATR | 3.24 Mid |
ADX | 32.8 Top | SSO | 79.9 Mid |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +13.22% Top | 19.34% Top | +9.20% Top |
10-day | +19.17% Top | 19.34% Mid | +11.39% Top |
20-day | +27.12% Top | 27.22% Mid | +16.25% Top |
50-day | +24.96% Mid | 52.31% Mid | +26.28% Top |
100-day | +13.51% Mid | 52.31% Mid | +19.85% Top |
200-day | +37.38% Mid | 65.92% Low | +17.67% Mid |
Choose Metric type
Select Performance timeframe above to analyze
On 2023-Dec-27, Axsome Therapeutics Inc had:daily change of +5.34% intraday volatility of 5.9% 4 ↑(up) day streak yielding +18.51% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2023-Dec-27 value annotated for comparison
Related to Axsome Therapeutics Inc
Information for Axsome Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-12 on Google
SEC Reports : Quarterly reports around 2025-May-12 on SEC Edgar
Compare Axsome Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Axsome Therapeutics Inc
Industry : Biotechnology industry performance which includes Axsome Therapeutics Inc